Does Dr. MEGHAN BRONKEMA have financial conflicts of interest?

Dr. MEGHAN BRONKEMA (PMHNP-BC) has received a total of $1,489 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,489 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MEGHAN BRONKEMA?

According to CMS Open Payments data, Dr. MEGHAN BRONKEMA received funding from AXSOME THERAPEUTICS ($419), ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .) ($237), and ALKERMES ($147).

Does Dr. MEGHAN BRONKEMA receive research grants or speaking fees?

Dr. MEGHAN BRONKEMA has received $1,489 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MEGHAN BRONKEMA

PMHNP-BCReal-Time Hydrated

Specialty: Nurse Practitioner, Psych/Mental Health

Practice Location: SEATTLE, WA 98125

NPI Number: 1912779000

LIFETIME INDUSTRY VALUE

$1,489

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BRONKEMA is a verified Nurse Practitioner, Psych/Mental Health practitioner based in SEATTLE, WA.

Between 2021 and 2025, Dr. BRONKEMA had an overall industry promotional and research financial footprint of $1,489 as recorded in the federal CMS Open Payments database.

$1,489 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BRONKEMA's primary funding source is AXSOME THERAPEUTICS, which accounts for $419 (representing 28.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

AXSOME THERAPEUTICS

Rank 1

$419

28.1%

ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .)

Rank 2

$237

16%

ALKERMES

Rank 3

$147

9.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.